ASLTY (Asymchem Laboratories Tianjin Co) YoY EBITDA Growth: -1.47% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASLTY Asymchem Laboratories Tianjin Co Ltd ASLTY
72 GF Score
Price $6.37
GF Value $4.68
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Asymchem Laboratories Tianjin Co YoY EBITDA Growth?

Asymchem Laboratories Tianjin Co ASLTY 72 YoY EBITDA Growth is -1.47% as of Mar. 2026. GuruFocus rates ASLTY with a GF Score™ of 72/100 and a GF Value™ of $4.68 (Significantly Overvalued). The stock has 9 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Asymchem Laboratories Tianjin Co's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was -1.47%.

Asymchem Laboratories Tianjin Co's EBITDA per Share for the three months ended in Mar. 2026 was $0.07.

Asymchem Laboratories Tianjin Co YoY EBITDA Growth Related Terms

Asymchem Laboratories Tianjin Co YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Asymchem Laboratories Tianjin Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asymchem Laboratories Tianjin Co YoY EBITDA Growth Chart

Asymchem Laboratories Tianjin Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.17 145.23 -26.60 -47.35 18.83

Asymchem Laboratories Tianjin Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.64 35.42 -10.87 30.65 -1.47
ASLTY
72GF Score
Asymchem Laboratories Tianjin Co Ltd ASLTY
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asymchem Laboratories Tianjin Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Asymchem Laboratories Tianjin Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.366-0.308)/ | 0.308 |
=18.83 %

Asymchem Laboratories Tianjin Co's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(0.067-0.068)/ | 0.068 |
=-1.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -1.47% mean?
Asymchem Laboratories Tianjin Co (ASLTY) has a YoY EBITDA Growth of -1.47% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Asymchem Laboratories Tianjin Co and its competitors.
Is Asymchem Laboratories Tianjin Co's YoY EBITDA Growth too high?
Asymchem Laboratories Tianjin Co's current YoY EBITDA Growth is -1.47%. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's YoY EBITDA Growth compare to VRTX and REGN?
Asymchem Laboratories Tianjin Co's YoY EBITDA Growth of -1.47% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Biotechnology company?
A good YoY EBITDA Growth depends on the Biotechnology industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Asymchem Laboratories Tianjin Co and its competitors. Asymchem Laboratories Tianjin Co's current YoY EBITDA Growth is -1.47%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.68, compared to a current price of $6.37 — trading 36.1% above its estimated fair value. The current YoY EBITDA Growth is -1.47%. Asymchem Laboratories Tianjin Co's overall GF Score™ is 72/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current YoY EBITDA Growth is -1.47% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?

Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued. The current stock price of $6.37 is trading 36.1% above its estimated GF Value™ of $4.68. GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.

Key valuation signals for ASLTY:

  • YoY EBITDA Growth: -1.47%
  • GF Value™: $4.68 vs. price of $6.37 (36.1% above fair value)
  • GF Score™: 72/100 with 9 warning signs

No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Asymchem Laboratories Tianjin Co Business Description

Other Exchanges 06821:Hong Kong002821:China
Address No. 6 Dongting 3rd Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
72GF Score

Get the complete analysis for ASLTY

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.37
Price
$4.68
GF Value